Tobramycin Sulfate
(C18H37N5O9)2·5H2SO4
![]() ![]() ![]() ![]() ![]() d-Streptamine, O-3-amino-3-deoxy- ![]() ![]() O-3-Amino-3-deoxy- ![]() ![]() ![]() ![]() ![]() » Tobramycin Sulfate has a potency of not less than 634 µg and not more than 739 µg of tobramycin (C18H37N5O9) per mg.
Packaging and storage
Preserve in tight containers.
Labeling
Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
Identification
B:
It responds to the tests for Sulfate
![]() ![]()
pH
![]() ![]()
Water, Method I
![]() ![]()
Other requirements
It meets the requirements for Residue on ignition, Heavy metals, and Chromatographic purity under Tobramycin. Where the label states that Tobramycin Sulfate is sterile, it meets the requirements for Sterility Tests
![]() ![]()
Assay
Mobile phase
, 2,4-Dinitrofluorobenzene reagent, Tris(hydroxymethyl)aminomethane reagent, Standard preparation, Derivatization procedure, Resolution solution, and Chromatographic systemProceed as directed in the Assay under Tobramycin.
Assay preparation
Transfer an accurately weighed quantity of Tobramycin Sulfate, equivalent to about 50 mg of tobramycin (C18H37N5O9), to a 250-mL volumetric flask, dissolve in and dilute with water to volume, and mix.
Procedure
Proceed as directed for Procedure in the Assay under Tobramycin. Calculate the quantity, in µg, of tobramycin (C18H37N5O9) in each mg of the Tobramycin Sulfate taken by the formula:
250(CE / W)(rU / rS)
in which the terms are as defined therein.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 3762
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|